Df Dent & CO Inc Eli Lilly & CO Transaction History

Df Dent & CO Inc

$7.62 Billion
Q3 2024

A detailed history of Df Dent & CO Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Df Dent & CO Inc holds 3,288 shares of LLY stock, worth $2.58 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,288

Previous 3,478 5.46%

Holding current value

$2.58 Million

Previous $3.15 Million 7.5%

% of portfolio

0.04%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $146,706 - $182,403	-190 Reduced 5.46%	3,288 $2.91 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $9,475 - $12,676	-16 Reduced 0.46%	3,478 $2.71 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $21,007 - $24,765	40 Added 1.16%	3,494 $2.04 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $12,275 - $16,414	-35 Reduced 1.0%	3,454 $1.62 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $201,909 - $237,133	-650 Reduced 15.7%	3,489 $1.2 Million
Q4 2022 Feb 15, 2023	SELL	$321.55 - $374.67 $394,863 - $460,094	-1,228 Reduced 22.88%	4,139 $1.51 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $889 - $1,013	-3 Reduced 0.06%	5,367 $1.74 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $7,979 - $9,916	-34 Reduced 0.63%	5,370 $1.54 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $16,189 - $20,090	-72 Reduced 1.31%	5,404 $1.49 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $4,513 - $5,838	-25 Reduced 0.45%	5,476 $1.26 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $130,460 - $172,630	-1,000 Reduced 15.38%	5,501 $929,000
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $206,170 - $238,473	-1,410 Reduced 17.82%	6,501 $962,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $163,703 - $197,016	1,200 Added 17.88%	7,911 $1.3 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $23,214 - $28,733	195 Added 2.99%	6,711 $931,000
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $65,541 - $81,179	-613 Reduced 8.6%	6,516 $856,000
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $10,679 - $11,616	-100 Reduced 1.38%	7,129 $797,000
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $3,877 - $4,526	-35 Reduced 0.48%	7,229 $801,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $26,603 - $31,313	-239 Reduced 3.19%	7,264 $943,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $10,590 - $11,864	100 Added 1.35%	7,503 $868,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $74,581 - $88,038	-1,005 Reduced 11.95%	7,403 $573,000
Q3 2017 Nov 15, 2017	BUY	$77.07 - $85.54 $648,004 - $719,220	8,408	8,408 $719,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Df Dent & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Df Dent & CO Inc with notifications on news.

Account